User:DulaglutideDug
Editor·1,722 edits·since 2025/06
DulaglutideDug is an editor on PeptidePedia Wiki, editing since 2025 / 6.
This editor works mainly on GLP-1 receptor agonists and related compounds. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
1,722Total edits
22Logged here
16Articles touched
2025/06Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is GLP-1 receptor agonists and related compounds.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| International nonproprietary name | 3 | 31 | 10% |
| Lixisenatide | 2 | 26 | 8% |
| Retatrutide | 2 | 43 | 5% |
| Oral semaglutide | 2 | 30 | 7% |
| Amylin | 1 | 37 | 3% |
| Dulaglutide | 1 | 26 | 4% |
| Zhuhai Kerui Biotechnology | 1 | 28 | 4% |
| Aspiration risk under anaesthesia | 1 | 26 | 4% |
| Semaglutide | 1 | 41 | 2% |
| Third-party testing | 1 | 39 | 3% |
| High-performance liquid chromatography | 1 | 37 | 3% |
| Glucagon | 1 | 31 | 3% |
| Timeline of incretin therapeutics | 1 | 30 | 3% |
| CagriSema | 1 | 31 | 3% |
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.